What is Indaptus Therapeutics, Inc. Common Stock's Market Cap?

Indaptus Therapeutics, Inc. Common Stock's Market Cap is $246.5M, based on as-reported figures from SEC (XBRL) filings.

What is Indaptus Therapeutics, Inc. Common Stock's Enterprise Value?

Indaptus Therapeutics, Inc. Common Stock's Enterprise Value is $234.9M, based on as-reported figures from SEC (XBRL) filings.

What is Indaptus Therapeutics, Inc. Common Stock's EV / EBITDA?

Indaptus Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Indaptus Therapeutics, Inc. Common Stock's Net Income (TTM)?

Indaptus Therapeutics, Inc. Common Stock's Net Income (TTM) is -$15.4M, based on as-reported figures from SEC (XBRL) filings.

What is Indaptus Therapeutics, Inc. Common Stock's EBITDA?

Indaptus Therapeutics, Inc. Common Stock's EBITDA is -$14.8M, based on as-reported figures from SEC (XBRL) filings.

What is Indaptus Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?

Indaptus Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -0.12, based on as-reported figures from SEC (XBRL) filings.

What is Indaptus Therapeutics, Inc. Common Stock's Net Debt?

Indaptus Therapeutics, Inc. Common Stock's Net Debt is -$11.6M, based on as-reported figures from SEC (XBRL) filings.

Indaptus Therapeutics, Inc. Common Stock (INDP) Financial Statements

Indaptus Therapeutics, Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG00ZNLVBD7

XNAS · usd

1.85▲ 0.63 (51.64%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close1.22

Day's Range1.27 – 1.94

52-Week Range0.92 – 8.57

Volume8.2M

Avg Volume890.0K

Share Statistics

Shares Outstanding

Employees5

ExchangeXNAS

Listed2021-08-04

Share count as of August 13, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Indaptus Therapeutics, Inc. Common Stock (INDP)

What is Indaptus Therapeutics, Inc. Common Stock's Market Cap?: Indaptus Therapeutics, Inc. Common Stock's Market Cap is $246.5M, based on as-reported figures from SEC (XBRL) filings.
What is Indaptus Therapeutics, Inc. Common Stock's Enterprise Value?: Indaptus Therapeutics, Inc. Common Stock's Enterprise Value is $234.9M, based on as-reported figures from SEC (XBRL) filings.
What is Indaptus Therapeutics, Inc. Common Stock's EV / EBITDA?: Indaptus Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Indaptus Therapeutics, Inc. Common Stock's Net Income (TTM)?: Indaptus Therapeutics, Inc. Common Stock's Net Income (TTM) is -$15.4M, based on as-reported figures from SEC (XBRL) filings.
What is Indaptus Therapeutics, Inc. Common Stock's EBITDA?: Indaptus Therapeutics, Inc. Common Stock's EBITDA is -$14.8M, based on as-reported figures from SEC (XBRL) filings.
What is Indaptus Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?: Indaptus Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -0.12, based on as-reported figures from SEC (XBRL) filings.
What is Indaptus Therapeutics, Inc. Common Stock's Net Debt?: Indaptus Therapeutics, Inc. Common Stock's Net Debt is -$11.6M, based on as-reported figures from SEC (XBRL) filings.